Assignee
ACADIA PHARM INC
US·84 granted patents·39 pending applications·1,730 citations·filing 1997–2025
Top patents by PatentIndex Score
123 records- 0198US8921393B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2013·Granted Dec 30, 2014·41 cites·36 claims
- 0297US10028944B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2017·Granted Jul 24, 2018·15 cites·15 claims
- 0397US9566271B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2015·Granted Feb 14, 2017·17 cites·15 claims
- 0497US8377959B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2012·Granted Feb 19, 2013·26 cites·12 claims
- 0597US8008323B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2010·Granted Aug 30, 2011·25 cites·9 claims
- 0697US7994193B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2010·Granted Aug 9, 2011·29 cites·9 claims
- 0797US7732462B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2006·Granted Jun 8, 2010·36 cites·24 claims
- 0897US7659285B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2006·Granted Feb 9, 2010·33 cites·11 claims
- 0997US7601740B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2004·Granted Oct 13, 2009·60 cites·26 claims
- 1097US6911452B2Spiroazacyclic compounds as monoamine receptor modulatorsACADIA PHARM INC·Filed 2002·Granted Jun 28, 2005·90 cites·16 claims
- 1196US10525046B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2018·Granted Jan 7, 2020·12 cites·20 claims
- 1296US9211289B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2014·Granted Dec 15, 2015·20 cites·13 claims
- 1396US7713995B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2006·Granted May 11, 2010·30 cites·15 claims
- 1496US6815458B2Azacyclic compoundsACADIA PHARM INC·Filed 2001·Granted Nov 9, 2004·85 cites·48 claims
- 1596US6756393B2Azacyclic compoundsACADIA PHARM INC·Filed 2003·Granted Jun 29, 2004·77 cites·5 claims
- 1695US11161826B2Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agentACADIA PHARM INC·Filed 2020·Granted Nov 2, 2021·3 cites·6 claims
- 1795US9296694B2Azacyclic compoundsACADIA PHARM INC·Filed 2015·Granted Mar 29, 2016·17 cites·4 claims
- 1895US8618130B2Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseasesACADIA PHARM INC·Filed 2013·Granted Dec 31, 2013·25 cites·15 claims
- 1995US7868176B2Salts of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-y1)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparationACADIA PHARM INC·Filed 2005·Granted Jan 11, 2011·33 cites·16 claims
- 2095US7863296B2Selective serotonin receptor inverse agonists as therapeutics for diseaseACADIA PHARM INC·Filed 2005·Granted Jan 4, 2011·47 cites·18 claims
- 2194US10981870B2Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic formACADIA PHARM INC·Filed 2020·Granted Apr 20, 2021·5 cites·12 claims
- 2294US10981871B2Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form CACADIA PHARM INC·Filed 2020·Granted Apr 20, 2021·5 cites·13 claims
- 2394US10849891B2Formulations of pimavanserinACADIA PHARM INC·Filed 2020·Granted Dec 1, 2020·8 cites·15 claims
- 2494US10449185B2Formulations of pimavanserinACADIA PHARM INC·Filed 2019·Granted Oct 22, 2019·12 cites·5 claims
- 2594US7923564B2Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy) phenylmethyl)carbamide and its tartrate salt and crystalline formsACADIA PHARM INC·Filed 2010·Granted Apr 12, 2011·26 cites·6 claims
- 2694US7875632B2Selective serotonin receptor inverse agonists as therapeutics for diseaseACADIA PHARM INC·Filed 2009·Granted Jan 25, 2011·23 cites·11 claims
- 2794US7732615B2N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline formsACADIA PHARM INC·Filed 2005·Granted Jun 8, 2010·29 cites·24 claims
- 2894US7351707B2Spiroazacyclic compounds as monoamine receptor modulatorsACADIA PHARM INC·Filed 2006·Granted Apr 1, 2008·22 cites·23 claims
- 2994US7217719B2Spiroazacyclic compounds as monoamine receptor modulatorsACADIA PHARM INC·Filed 2005·Granted May 15, 2007·24 cites·35 claims
- 3094US6951849B2Benzimidazolidinone derivatives as muscarinic agentsACADIA PHARM INC·Filed 2003·Granted Oct 4, 2005·44 cites·21 claims
- 3193US10646480B2Formulations of pimavanserinACADIA PHARM INC·Filed 2019·Granted May 12, 2020·9 cites·20 claims
- 3293US10597363B2Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form CACADIA PHARM INC·Filed 2016·Granted Mar 24, 2020·10 cites·15 claims
- 3393US7790899B2Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline formsACADIA PHARM INC·Filed 2007·Granted Sep 7, 2010·32 cites·9 claims
- 3493US7538222B2N-substituted piperidine derivatives as serotonin receptor agentsACADIA PHARM INC·Filed 2005·Granted May 26, 2009·19 cites·24 claims
- 3593US7491715B2Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disordersACADIA PHARM INC·Filed 2006·Granted Feb 17, 2009·32 cites·19 claims
- 3693US6528529B1Compounds with activity on muscarinic receptorsACADIA PHARM INC·Filed 1999·Granted Mar 4, 2003·195 cites·88 claims
- 3793US5955281AIdentification of ligands by selective amplification of cells transfected with receptorsACADIA PHARM INC·Filed 1997·Granted Sep 21, 1999·103 cites·13 claims
- 3893US5912132AIdentification of ligands by selective amplification of cells transfected with receptorsACADIA PHARM INC·Filed 1997·Granted Jun 15, 1999·103 cites·14 claims
- 3992US11827600B2Crystalline forms of trofinetideACADIA PHARM INC·Filed 2022·Granted Nov 28, 2023·3 cites·19 claims
- 4092US10517860B2Combination of pimavanserin and cytochrome P450 modulatorsACADIA PHARM INC·Filed 2019·Granted Dec 31, 2019·11 cites·5 claims
- 4191US7476682B2N-substituted piperidine derivatives as serotonin receptor agentsACADIA PHARM INC·Filed 2006·Granted Jan 13, 2009·23 cites·50 claims
- 4291US7087593B2Benzimidazolidinone derivatives as muscarinic agentsACADIA PHARM INC·Filed 2002·Granted Aug 8, 2006·34 cites·19 claims
- 4390US11452721B2Formulations of pimavanserinACADIA PHARM INC·Filed 2022·Granted Sep 27, 2022·1 cites·13 claims
- 4490US7517871B2Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disordersACADIA PHARM INC·Filed 2006·Granted Apr 14, 2009·17 cites·21 claims
- 4589US7300928B2Benzimidazolidinone derivatives as muscarinic agentsACADIA PHARM INC·Filed 2006·Granted Nov 27, 2007·7 cites·21 claims
- 4689US7268232B2Androgen receptor modulators and method of treating disease using the sameACADIA PHARM INC·Filed 2005·Granted Sep 11, 2007·26 cites·10 claims
- 4788US9757366B2Methods for the treatment of parkinson's disease psychosis using pimavanserinACADIA PHARM INC·Filed 2016·Granted Sep 12, 2017·14 cites·6 claims
- 4888US7622461B2Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disordersACADIA PHARM INC·Filed 2007·Granted Nov 24, 2009·12 cites·26 claims
- 4988US7511053B2Spiroazacyclic compounds as monoamine receptor modulatorsACADIA PHARM INC·Filed 2007·Granted Mar 31, 2009·7 cites·24 claims
- 5088US7291611B2Benzimidazolidinone derivatives as muscarinic agentsACADIA PHARM INC·Filed 2005·Granted Nov 6, 2007·6 cites·23 claims
Showing the top 50 of 123 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ACADIA PHARM INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →